1. LAVA Therapeutics under investigation for proposed sale to XOMA Royalty. 2. Shareholders may not receive fair value from the acquisition deal. 3. XOMA plans to acquire LAVA at $1.16 per share plus contingent rights. 4. Investigation raises concerns about fiduciary responsibilities of LAVA's board. 5. Class action firm has a history of recovering funds for shareholders.
The investigation into LAVA's sale indicates potential undervaluation for shareholders, likely contributing to lower investor confidence. Historically, similar investigations have negatively affected stock prices, as seen with companies facing regulatory scrutiny before acquisitions.
The investigation by a reputable firm may significantly affect shareholder perception and market valuation. Given the ongoing regulatory scrutiny and its implications for the sale, the impact on LVTX's price is likely to be pronounced.
Immediate investor reaction to the investigation may lead to a short-term price drop. Past incidents show that news regarding class actions can have a quick impact on stock prices.
NEW YORK, Aug. 7, 2025 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report. The firm is headquartered at the Empire State Building in New York City and is investigating LAVA Therapeutics N.V. (NASDAQ: LVTX) related to its sale to XOMA Royalty Corporation. Under the terms of the proposed transaction, XOMA Royalty will acquire LAVA for $1.16 in cash per share, plus up to $0.08 per share and a non-transferable contingent value right per share representing the right to receive 75% of the net proceeds related to LAVA's two partnered assets and 75% of any net proceeds from any out license sale of LAVA's unpartnered programs. Is it a fair deal?
Click here for more info https://monteverdelaw.com/case/lava-therapeutics-n-v/. It is free and there is no cost or obligation to you.
NOT ALL LAW FIRMS ARE EQUAL. Before you hire a law firm, you should talk to a lawyer and ask:
About Monteverde & Associates PC
Our firm litigates and has recovered money for shareholders…and we do it from our offices in the Empire State Building. We are a national class action securities firm with a successful track record in trial and appellate courts, including the U.S. Supreme Court.
No one is above the law. If you own common stock in the above listed company and have concerns or wish to obtain additional information free of charge, please visit our website or contact Juan Monteverde, Esq. either via e-mail at jmonteverde@monteverdelaw.com or by telephone at (212) 971-1341.
Contact:
Juan Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave. Suite 4740
New York, NY 10118
United States of America
jmonteverde@monteverdelaw.com
Tel: (212) 971-1341
Attorney Advertising. (C) 2025 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com). Prior results do not guarantee a similar outcome with respect to any future matter.
View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-alert-the-ma-class-action-firm-announces-an-investigation-of-lava-therapeutics-nv-nasdaq-lvtx-302524852.html
SOURCE Monteverde & Associates PC